Please have a look at this brief essay in the July edtion of Nature Biotechnology.
The topic is FDA advisory committies and conflicts of interest -- a topic that regular readers of Drugwonks are most familiar with.
Here's a link:
http://cmpi.org/archives/2007/07/settling_for_second_best.php
You'll find some tough questions about the infamous $50,000 limit. For example, does that also include dollars earned by adcomm members who have served as expert witnesses in court trials against pharmaceutical firms?
Or what about fees that are earned but later contributed to a charity?
Anyone come to mind?
The topic is FDA advisory committies and conflicts of interest -- a topic that regular readers of Drugwonks are most familiar with.
Here's a link:
http://cmpi.org/archives/2007/07/settling_for_second_best.php
You'll find some tough questions about the infamous $50,000 limit. For example, does that also include dollars earned by adcomm members who have served as expert witnesses in court trials against pharmaceutical firms?
Or what about fees that are earned but later contributed to a charity?
Anyone come to mind?
